DexCom Inc (DC4.HA)
| Previous Close | 102.68 |
| Open | 105.66 |
| Bid | 105.58 x N/A |
| Ask | 105.90 x N/A |
| Day's Range | 105.66 - 105.66 |
| 52 Week Range | 71.37 - 130.20 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireDexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
SAN DIEGO, June 27, 2024--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call to review the company's second quarter 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be
Barrons.comDid Your Heart Just Skip a Beat? Your Watch Already Knows That and More.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
Simply Wall St.DexCom (NASDAQ:DXCM) shareholders have earned a 26% CAGR over the last five years
It hasn't been the best quarter for DexCom, Inc. ( NASDAQ:DXCM ) shareholders, since the share price has fallen 18% in...
